Close
Nordic 9Nordic 9

Catalio Capital Management (investor - Venture Capital)

United States cataliocapital.com
See something wrong or missing? Let us know
Offices:Baltimore

Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies

Average round investment:141.6M USD
Average number per year:1.2
Distribution: 2025 (1)2024 (1)2023 (1)2021 (2)
Portfolio companies: Switzerland GlycoEraSwitzerland Alentis TherapeuticsSwitzerland Rejuveron Life Sciences See the entire list
Mostly invests in: Switzerland Switzerland (3) Health services (5)
See the entire list

Showing 3 of 5 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Catalio Capital Management

Name Criteria
Switzerland Mountain Partners
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Financial Services, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland, Germany
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Wellington Management
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Biotech, Financial Services, Software Services
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Farallon Capital Management
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Financial Services, Software Services
  • Similar business models: B2B
  • Common investees countries: France, Germany
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
France Natixis Private Equity
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Financial Services, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United Arab Emirates Chimera Investment
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Biotech, Financial Services, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United States Concord Health Partners
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Biotech, Software Services
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States G2VP
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Financial Services, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: Switzerland, Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Israel FinTLV Ventures
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Financial Services, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: France, Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Munich Re Ventures
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Financial Services, Software Services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Viking Global Investors
83%
  • Range for average deal size: 100M+ USD
  • Similar verticals: Health services, Biotech, Pharma, Financial Services, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Top